Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Scott Obach

Showing results (31-40 of 193) with videos related to

Pageof 20
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2002
Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate depletion approachR Scott Obach, Anne E Reed-Hagen
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 18, 2010
A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessmentsHongying Gao, Shibing Deng, R Scott Obach
Analytical Chemistry|November 4, 2015
Unbiased Scanning Method and Data Banking Approach Using Ultra-High Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry for Quantitative Comparison of Metabolite Exposure in Plasma across Species Analyzed at Different DatesHongying Gao, Shibing Deng, R Scott Obach
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 4, 2012
In vitro metabolism of the 5-hydroxytryptamine1B receptor antagonist elzasonanAmin Kamel, Kevin Colizza, R Scott Obach
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 18, 2018
Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug CompoundsFranco Lombardo, Giuliano Berellini, R Scott Obach
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 12, 2025
Impact of cytosolic aldehyde oxidase contamination in liver microsomes on intrinsic clearance estimationsLloyd Wei Tat Tang, R Scott Obach
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 8, 2012
Reduction and methylation of ziprasidone by glutathione, aldehyde oxidase, and thiol S-methyltransferase in humans: an in vitro studyR Scott Obach, Chandra Prakash, Amin M Kamel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 23, 2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compoundsR Scott Obach, Franco Lombardo, Nigel J Waters
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 22, 2016
The Use of In Vitro Data and Physiologically-Based Pharmacokinetic Modeling to Predict Drug Metabolite Exposure: Desipramine Exposure in Cytochrome P4502D6 Extensive and Poor Metabolizers Following Administration of ImipramineHoa Q Nguyen, Ernesto Callegari, R Scott Obach
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Consideration of the unbound drug concentration in enzyme kineticsNigel J Waters, R Scott Obach, Li Di
Pageof 20

Showing results (31-40 of 193) with videos related to

Sort By:
Pageof 20
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2002
Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate depletion approachR Scott Obach, Anne E Reed-Hagen
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 18, 2010
A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessmentsHongying Gao, Shibing Deng, R Scott Obach
Analytical Chemistry|November 4, 2015
Unbiased Scanning Method and Data Banking Approach Using Ultra-High Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry for Quantitative Comparison of Metabolite Exposure in Plasma across Species Analyzed at Different DatesHongying Gao, Shibing Deng, R Scott Obach
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 4, 2012
In vitro metabolism of the 5-hydroxytryptamine1B receptor antagonist elzasonanAmin Kamel, Kevin Colizza, R Scott Obach
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 18, 2018
Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug CompoundsFranco Lombardo, Giuliano Berellini, R Scott Obach
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 12, 2025
Impact of cytosolic aldehyde oxidase contamination in liver microsomes on intrinsic clearance estimationsLloyd Wei Tat Tang, R Scott Obach
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 8, 2012
Reduction and methylation of ziprasidone by glutathione, aldehyde oxidase, and thiol S-methyltransferase in humans: an in vitro studyR Scott Obach, Chandra Prakash, Amin M Kamel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 23, 2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compoundsR Scott Obach, Franco Lombardo, Nigel J Waters
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 22, 2016
The Use of In Vitro Data and Physiologically-Based Pharmacokinetic Modeling to Predict Drug Metabolite Exposure: Desipramine Exposure in Cytochrome P4502D6 Extensive and Poor Metabolizers Following Administration of ImipramineHoa Q Nguyen, Ernesto Callegari, R Scott Obach
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Consideration of the unbound drug concentration in enzyme kineticsNigel J Waters, R Scott Obach, Li Di
Pageof 20